FIELD: organic chemistry, biochemistry, medicine, endocrinology.
SUBSTANCE: invention relates to O-arylglucoside inhibitors of SGLT2 of the formula (I): 
wherein Y means compounds of formulae: 
A means -O(CH2)m, sulfur atom (S), -NH(CH2)m or -(CH2)n wherein n = 0-3; m = 0-2; R1-R6 are determined above, and to a pharmaceutical composition based on thereof, and to methods for treatment of diabetes mellitus type 2, and micro- and macrovascular diabetic complications.
EFFECT: valuable medicinal properties of inhibitors.
15 cl, 1 tbl, 99 ex
| Title | Year | Author | Number |
|---|---|---|---|
| C-ARYLGLUCOSIDE INHIBITORS OF SGLT-2 | 2000 |
|
RU2262507C2 |
| C-ARYL GLUCOSE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2800510C1 |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR USE | 2020 |
|
RU2746132C1 |
| METHODS FOR SGLT2 INHIBITOR OBTAINING AND APPLICATION | 2013 |
|
RU2643764C2 |
| C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD OF THEIR APPLICATION | 2003 |
|
RU2337916C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| DIPEPTIDYL PEPTIDASE IV INHIBITORS BASED ON CONDENSED CYCLOPROPYLPYRROLIDINES AND METHOD FOR THEIR USING | 2001 |
|
RU2286986C2 |
| LIGANDS OF THYROID RECEPTORS: DERIVATIVES OF ANILINE | 2001 |
|
RU2260586C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
